Dosage form preference consultation study in children and young adults: paving the way for patient-centred and patient-informed dosage form development

Objectives The current study aims to evaluate dosage form preferences in children and young adults together with identifying the key pragmatic dosage form characteristics that would enable appropriate formulation of orally disintegrating tablets (ODTs). Methods International, multisite, cross-sectional questionnaire of children and young adults aged from 6 to 18 years. Eligibility was based on age, ability to communicate and previous experience in taking medications. The study was carried out at three locations: the UK, Saudi Arabia and Jordan. The questionnaire instrument was designed for participant self-completion under supervision of the study team. Results 104 questionnaires were completed by the study cohort (n=120, response rate 87%). Results showed that ODTs were the most preferred oral dosage forms (58%) followed by liquids (20%), tablets (12%) and capsules (11%). The preferred colours were pink or white while the preferred size was small (<8 mm) with a round shape. With regard to flavour, strawberry was the most preferred (30.8%), while orange was the least preferred (5.8%). The results also showed that the most important physical characteristics of ODTs were disintegration time followed by taste, size and flavour, respectively. Conclusions The results of our study support the WHO’s claim for a shift of paradigm from liquid towards ODTs dosage forms for drug administration to young children older than 6 years. Data from this study will also equip formulators to prioritise development of key physical/performance attributes within the delivery system.

[1]  M. Sheelagh T. Carpendale,et al.  Analyzing Qualitative Data , 2017, ISS.

[2]  Qasem M A Abdallah,et al.  General public knowledge, preferred dosage forms, and beliefs toward medicines in western Saudi Arabia. , 2014, Saudi medical journal.

[3]  H. Kristensen WHO guideline development of paediatric medicines: points to consider in pharmaceutical development. , 2012, International journal of pharmaceutics.

[4]  J. Breitkreutz,et al.  Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study , 2012, Archives of Disease in Childhood.

[5]  J. Cardot,et al.  Developing Drugs for Children and the Adjustment of Medication—Is It a New Challenge or an Adaptation of Past Ideas? , 2011, Journal of personalized medicine.

[6]  C. Tuleu,et al.  European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary--Formulating better medicines for children. , 2011, International journal of pharmaceutics.

[7]  G. Kearns,et al.  The status of paediatric medicines initiatives around the world—what has happened and what has not? , 2011, European Journal of Clinical Pharmacology.

[8]  S. Abdulla,et al.  Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects , 2010, Malaria Journal.

[9]  S. Lewis,et al.  Taste masking technologies: A review , 2010 .

[10]  J. Breitkreutz European perspectives on pediatric formulations. , 2008, Clinical therapeutics.

[11]  K. Hoppu Paediatric clinical pharmacology—at the beginning of a new era , 2008, European Journal of Clinical Pharmacology.

[12]  J. Mennella,et al.  Sucrose-induced analgesia is related to sweet preferences in children but not adults , 2005, Pain.

[13]  Elizabeth J. Wilkinson,et al.  The use of visual information for planning accurate steps in a cluttered environment , 2005, Behavioural Brain Research.

[14]  R. Viner,et al.  Young people's health: the need for action , 2005, BMJ : British Medical Journal.

[15]  D. Reed,et al.  Genetic and Environmental Determinants of Bitter Perception and Sweet Preferences , 2005, Pediatrics.

[16]  L. Christrup,et al.  Patients' evaluation of shape, size and colour of solid dosage forms , 2001, Pharmacy World and Science.

[17]  M. Nahata Lack of pediatric drug formulations. , 1999, Pediatrics.

[18]  T. Reisenwitz,et al.  Over-the-counter pharmaceuticals: exploratory research of consumer preference toward solid oral dosage forms. , 1996, Health Marketing Quarterly.

[19]  F. Crane,et al.  A consumer evaluation of health warning labels on cigarette packages in Canada. , 1996, Health Marketing Quarterly.

[20]  G. Beauchamp,et al.  Longitudinal changes in sweet preferences in humans , 1987, Physiology & Behavior.

[21]  J. Virjee,et al.  The Effect of Size and Shape of Tablets on Their Esophageal Transit , 1986, Journal of clinical pharmacology.

[22]  M. Rajaniemi,et al.  Effect of dosage form and formulation factors on the adherence of drugs to the esophagus. , 1983, Journal of pharmaceutical sciences.

[23]  H. Hasselbalch,et al.  Oesophageal transit of six commonly used tablets and capsules. , 1982, British medical journal.